Introduction
POEMS syndrome is a multi-system disease characterized by polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes. Other common associated features include extravascular volume overload, Castleman disease, sclerotic bone lesions, papilledema, and thrombocytosis. The pathogenesis of this rare clonal plasma cell disorder is not well understood, although a causative role for elevated serum vascular endothelial growth factor (VEGF) in this syndrome has been proposed. The median survival time after diagnosis is usually more than 5 years, with renal failure, infection, and cardiopulmonary failure as the most frequent causes of death [1] [2] .
Pulmonary hypertension (PH) is thought to be an uncommon feature of POEMS syndrome.
Cases of PH in patients with POEMS syndrome have been reported in the literature [3] [4] [5] [6] [7] [8] [9] ; however, a comprehensive review of PH in POEMS syndrome is lacking. Therefore, we sought to characterize the prevalence, clinical correlates, response to treatment, and prognostic significance of PH in a retrospective study of a population of POEMS syndrome patients.
Design and M ethods

Patients
We retrospectively reviewed medical records of 167 cases with a clinical diagnosis of POEMS syndrome in Peking Union Medical College Hospital from 2001 to 2011. Of these, 154 patients with complete data of Doppler echocardiography (DE) at the time of diagnosis were identified. These patients were referred to our hospital from more than 30 centers throughout the whole country. Based on the criteria from Dispenzieri A et al [10] , all patients met two major criteria (polyneuropathy and monoclonal plasma proliferative disorder) and at least one of seven minor criteria (bone lesion, Castleman disease, organomegaly, edema, endocrinopathy, skin changes, and papilledema). This study was approved by Institutional Review Board of Peking Union Medical College Hospital. The following data were collected by chart review at the time of diagnosis: demographic information including age, gender, and time from onset to diagnosis; clinical symptoms of cough, and dyspnea; and POEMS related features of neuropathy, organomegaly (lymphadenopathy, splenomegaly, and hepatomegaly), M protein, skin changes, extravascular volume overload (edema, ascites, and pleural effusion), bone lesions, serum creatinine clearance rate (CLCr), plasma cell in bone marrow, anemia, thrombocytosis and serum VEGF level. Organomegaly and extravascular volume status were evaluated by physical examination, ultrasound or computed tomography scanning. Diagnosis of bone lesion was based on a complete x-ray's survey of bone (including skull, spine, pelvis, humerus and femur) without biopsy. The percent of plasma cells was determined from bone marrow aspiration. Serum VEGF level was measured as described previously [11] .
Measurement of sPA P and definition of PH
Two of authors (L.J. and T.Z) reviewed and analyzed DE data. DE examination was performed with duplex cardiac ultrasound system (Vivid E9 or Vivid 7, GE Medical Systems, Horton, Norway) with a 1.5-4.5 MHz phased-array transducer. Transthoracic Doppler and two-dimensional images were obtained from standard parasternal long and short axis views and apical two-chamber and four-chamber views. Left ventricular volumes were calculated from orthogonal apical views using the biplane area-length method. Ejection fraction was calculated by Simpson's rule [12] . Right ventricular dimension was measured from apical four-chamber view. Tricuspid regurgitant flow was identified by color-flow Doppler, and the peak velocity was measured by continuous-wave Doppler. Systolic pulmonary arterial pressure (sPAP) was estimated based on the modified Bernoulli equation: sPAP=4v 2 (v=peak velocity of tricuspid regurgitation) +right atrial pressure (RAP) [13] . The RAP was derived by the diameter of the inferior vena cava and the collapsibility index. PH was defined as sPAP 
Pulmonary function tests
The percentage of predicted FEV1, FVC, total volume capacity (TLC), and diffusion capacity of carbon monoxide (DLCO), and the value of FEV1/FVC ratio were abstracted and recorded from initial reports of pulmonary function tests at the time of diagnosis. According to guidelines described previously [15] , patients with predicted TLC less than 80% or predicted FVC less than 80% but with normal FEV1/FVC ratio were considered as those with restrictive abnormalities. Patients with FEV1/FVC less than 75% were defined as those with obstructive abnormalities. Decreased DLCO was defined as DLCO less than 80% of predicted.
The initial arterial oxygen pressure and carbon dioxide pressure were also recorded.
Treatment and follow-up
Treatment data were recorded from medical records. Authors tried to contact all patients and the treating physicians to obtain the follow-up data including death and cause of death via telephone, mail or email. Patients with at least one follow-up echocardiography study after treatment were identified. PH response was defined as a decrease in sPAP to less than 50mmHg after treatment. Overall survival was calculated as the time from diagnosis to death or to the time of last visit.
Statistical analysis
Data was analyzed with the statistical software SPSS 17.0 (SPSS, Inc., Chicago, IL 
Results
Clinical characteristics of patients with PH
Forty-two of 154 (27%) patients with adequate DE data were identified as those with PH.
Fifty-five percent of patients were male and the median age was 46 years (range, 31-71).
Polyneuropathy and M protein were observed in all patients. The median time from onset to diagnosis was 26 months (range, 5-120). The type of M protein was restrictively derived from lambda light chain including IgA-lambda (67%), IgG-lambda (21%) and lambda alone (12%). 
Comparison of clinical features between patients with and without PH
Relationship between PH and PFTs
Eighty three of the 154 patients with DE data underwent PFTs at the time of diagnosis.
Decreased DLCO was the most common PFTs abnormality, observed in 78% of patients.
Restrictive lung disease was present in 59% and obstructive lung disease in 2%.
We compared the indexes of PFTs and arterial blood gas results between patients with and without PH ( Therefore, the incidence of restrictive abnormality (83% vs 50%, P=0.007) and decreased DLCO (96% vs 72%, P=0.04) was higher in patients with PH than in those without PH. 
Treatment, PH response and survival
Discussion
To our knowledge, the current study is the largest series of POEMS syndrome and PH. It had been reported that PH occurs in 33-48% of patients with POEMS syndrome, depending on the definition of PH and the size of series. In the present study, we found prevalence for PH of 27% in 154 patients, using DE for evaluation for PH, with a sPAP of 50 mmHg as the cutoff.
This cutoff value is recommended for the diagnosis of likely PH, according to recently published guidelines of the European Respiratory Society and European Society of
Cardiology [14] .
The pathogenesis of POEMS related PH is not clear. However, sPAP measured from DE cannot distinguish pulmonary arterial hypertension from pulmonary venous hypertension from severe left ventricular dysfunction. Additional catheterization data for evaluation of PH were lacking due to the retrospective nature of this study. Pulmonary venous hypertension (or post-capillary hypertension) is less likely in our patients. All our patients with PH had normal LVEF. Diastolic function was not able to be assessed due to incomplete documentations and measurements. However, severe diastolic dysfunction with pulmonary venous hypertension is most commonly observed in elderly subjects and therefore is not a likely cause of PH in this relatively young patient population. Cytokine mediated proliferation of endothelial cells with resultant pulmonary vasculopathy is thought to be one of causative mechanisms of PH in POEMS syndrome [5, [16] [17] [18] . VEGF, a key proinflammatory cytokine for POEMS syndrome, can cause microvascular hyperpermeability leading to extravascular volume overload, stimulate excess endothelial proliferation, activate vascular smooth cell, and induce vascular endothelial dysfunction [19] [20] [21] [22] . In our study, we found that PH was significantly associated with signs of extravascular volume overload (edema, ascites, and pleural effusion). The signs of extravascular volume overload were not likely induced by PH, which was not supported by lack of evidences of right ventricular failure (normal right ventricular dimension and inferior vena cava dimension). Accordingly these findings suggest that PH might be one of downstream presentations similar to extravascular volume overload caused by the similar mechanism including excess serum VEGF. In addition, the finding that the improvement of PH to treatment was accompanied with reduction of serum VEGF level also suggests that PH is closely related to serum VEGF level, regardless of its causal relationship.
However, there was no difference in serum VEGF level between patients with and without PH in this study. It is not surprising because the absolute value of serum VEGF level is not associated with the severity of symptoms and patients with low serum VEGF may have more severe symptoms than those with high level of VEGF, and VEGF may not be the only explanation for these symptoms based on the conflicting results of anti-VEGF antibody therapy [23] [24] .
In our study, we found that patients with PH had longer time from onset to diagnosis than those without PH. Allam et al [4] also reported that 6% patients developed PH over the follow-up time. Therefore, the prevalence of PH in POEMS syndrome might be associated with the duration of disease.
PH patients reported more symptom of dyspnea than non-PH patients despite similar arterial oxygen pressure in two groups. Decreased DLCO and restrictive abnormality are common PFT abnormalities in patients with POEMS syndrome. This finding is consistent with that reported by Dispenzieri et al, although we did not record inspiratory and expiratory pressures to document the role of neuromuscular weakness in this study. The restrictive abnormality and decreased DLCO were more common in patients with PH than in patients without PH.
Pleural effusion, ascites and organomegaly also could contribute to these two PFTs abnormalities. The potential pulmonary interstitial edema associated with extravascular volume overload might be another mechanism.
Several studies have reported that PH in POEMS syndrome is reversible after successful treatment of POEMS syndrome including ASCT, MDex, and corticoid [5-6, 8-9, 25-27] . In our study, the PH response rate was 88% in 33 patients at a median 8 months after treatment.
96% patients who received melphalan based therapy achieved PH response, which was higher than those who received prednisone or dexamethasone alone (50%). The reversibility of PH may partially explain the longer median survival of 54 months in our cohort when compared with a median survival of 2.8 years in a previous report of POEMS syndrome patients with symptomatic PH [28] .
Although a high rate of PH response to treatments was observed in this study, we found that patients with PH had worse median survival than those without (54 months vs did not reach,
P=0.021).
High early mortality due to aggressive disease might contribute to this shorter survival as three patients died within one month after diagnosis (without treatment) and 62% patients died of disease progression related complications (renal failure, or cardiopulmonary failure). However, it is noteworthy that no one died of disease progression in patients receiving ASCT or MDex and only two patients died of treatment related infections.
Therefore, active treatments including ASCT and MDex may improve prognosis of patients with POEMS syndrome and PH. Novel agents (thalidomide, lenalidomide, and bortezomib) might also be used for patients with aggressive POEMS syndrome.
Our study has several limitations due to its retrospective nature. First, our patients did not have available hemodynamic data from right heart catheterization. Right heart catheterization is the recommended test for the definitive diagnosis of pulmonary hypertension. However, risks related to this its invasive procedure limits its routine use in the clinical practice. DE is widely available, cost effective, and has been established as non-invasive screening technique for the detection of PH. Second, the estimated sPAP from DE is subject to variations of the signal quality of tricuspid regurgitant flow and Doppler alignment. It can overestimate or underestimate the sPAP or right ventricular systolic pressure [29] . Third, the time period to the follow-up DE in 33 patients with PH to evaluate the response to the therapy was very heterogeneous and thus might impact the accurate estimation of the degree of response to the specific therapy. The findings of significant reduction in the mean sPAP and concomitant significant reduction of serum VEGF level do not allow inference of a causal connection but are nonetheless interesting hypothesis generating observations that require further study in prospective study.
In conclusion, PH is a common clinical feature of POEMS syndrome. All patients with POEMS syndrome should be assessed or screened for PH by DE, especially for patients with signs of extravascular volume overload. Most of PH in POEMS syndrome is reversible or partially reversible after successful treatment. PH is also a negative prognostic factor for survival of POEMS syndrome patients. Active treatments including MDex, ASCT and novel agents may improve outcome of this special group of patients. The findings of this retrospective study should be validated in prospective studies.
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